UniProtKB/Swiss-Prot Q99728: Variant p.Cys557Ser

BRCA1-associated RING domain protein 1
Gene: BARD1
Feedback?

Variant information Variant position:

557 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Cysteine (C) to Serine (S) at position 557 (C557S, p.Cys557Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (C) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs28997576 [ dbSNP | Ensembl ]

Sequence information Variant position:

557 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

777 The length of the canonical sequence.
Location on the sequence:

ESMKSLLLLPEKNESSSASH C SVMNTGQRRDGPLVLIGSGL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         E-SMKSLLLLPEKNESSSASHCSV-MNTGQRRDGPLVLIGSGL--

Mouse                         E-NIRSLLLLPEENESFSTSQCSI-VNTGQRKNGPLVFIGS

Rat                           E-NIRSLLLLPEKTDSFSTSQCSVQVNTGQRKSGPLVLIGS

Caenorhabditis elegans        DPKIRKII---EKFKTEQRVLQPV-VAPPKSRLHFVQLIDE

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 777	BRCA1-associated RING domain protein 1
Region	554 – 558	Flexible linker
Cross	548 – 548	Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
Alternative sequence	128 – 777	Missing. In isoform gamma.

Literature citations
Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.
Thai T.H.; Du F.; Tsan J.T.; Jin Y.; Phung A.; Spillman M.A.; Massa H.F.; Muller C.Y.; Ashfaq R.; Mathis J.M.; Miller D.S.; Trask B.J.; Baer R.; Bowcock A.M.;
Hum. Mol. Genet. 7:195-202(1998)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS SER-24; GLU-153; SER-378; MET-507; SER-557; HIS-564; CYS-658; LEU-695 AND ASN-761;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.